Formation and Urinary Excretion of Arsenic Triglutathione and Methylarsenic Diglutathione

Chemical Research in Toxicology

Volumn 17, Issue 2, 2004, Pages 243-249

  Kala, Subbarao V ^a   Kala, Geeta ^a   Prater, Christopher I ^a   Sartorelli, Alan C ^b   Lieberman, Michael W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ARSENIC; ARSENIC DERIVATIVE; ARSENIC TRIGLUTATHIONE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; METHYLARSENIC DIGLUTATHIONE; UNCLASSIFIED DRUG; VERLUKAST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; METABOLISM; MOUSE; NONHUMAN; SYNTHESIS; URINARY EXCRETION;

ANIMALS; ARSENICALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MASS SPECTROMETRY; MICE; RATS;

ANIMALIA; RODENTIA;

EID: 1342331929     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0342060     Document Type: Article

References (48)

1. National Research Council (1999) Arsenic in Drinking Water, National Academy Press, Washington DC.
2. Bates, M. N., Smith, A. H., and Hopenhayn-Rich, C. (1992) Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol. 135, 462-476.
3. Chen, C. J., Chen, C. W., Wu, M. M., and Kuo, T. L. (1992) Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66, 888-892.
4. Klaassen, C. D., Amdur, M. O., and Doull, J. (1996) Casarett and Doull's Toxicology: The Basic Sciences of Poisons, pp 691-736, McGraw-Hill, New York.
5. Tsai, S., Wang, T., and Ko, Y. (1999) Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch. Environ. Health 54, 186-193.
6. Thomas, D. J., Styblo, M., and Lin, S. (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176, 127-144.
7. Aposhian, H. V. (1997) Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37, 397-419.
8. Vahter, M. (1994) Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 8, 175-182.
9. Hughes, M. F., Menache, M., and Thompson, D. J. (1994) Dose dependent disposition of sodium arsenate in mice following acute oral exposure. Fundam. Appl. Toxicol. 22, 80-89.
10. Van Aubel, R. A. M. H., Masereeuw, R., and Russel, F. G. M. (2000) Molecular pharmacology of renal organic anion transporters. Am. J. Physiol. Renal Physiol. 279, F216-F232.
11. Lieberman, M. W., Barrios, R., Carter, B. Z., Habib, G., Lebovitz, R. M., Rajagopalan, S., Sepulveda, A., Shi, Z. Z., and Wan, D. F. (1995) gamma-Glutamyltranspeptidase. What does the organization and expression of multipromoter gene tell us about its functions? Am. J. Pathol. 147, 1175-1185.
12. Commandeur, J. N., Stijntjes, G. J., and Vermeulen, N. P. (1995) Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol. Rev. 47, 271-330.
13. Lieberman, M. W., Wiseman, A. L., Shi, Z. Z., Carter, B. Z., Barrios, R., Ou, C. N., Chevez-Barrios, P., Wang, Y., Habib, G. M., Goodman, J. C., Huang, S. L., Lebovitz, R. M., and Matzuk, M. M. (1996) Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93, 7923-7926.
14. Zaman, G. J. R., Lankelma, J., Van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Elferink, R. P. J. O., Baas, F., and Borst, P. (1995) Role of glutathione in the export of compounds from cells by the multidrug resistance-associated protein. Proc. Natl. Acad. Sci. U.S.A. 92, 7690-7694.
15. Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C. T. M., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., and Elferink, R. P. J. O. (1996) Congenital jaundice in rats with a mutation in multidrug resistance associated protein gene. Science 271, 1126-1128.
16. Cole, S. P., Bharadwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654.
17. Flens, M. J., Zaman, G. J. R., Van der Valk, P., Izquierdo, M. A., Scharoeijers, A. B., Scheffer, G. L., Van der Groep, P., de Haas, M., Meijer, C. J. L. M., and Scheper, R. J. (1996) Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148, 1237-1247.
18. Borst, P., Evers, R., Kool, M., Wijnholds, J. (1999) The multidrug resistance protein family. Biochim. Biophys. Acta 1461, 347-357.
19. Muller, M., Meijer, C., Zaman, G. J. R., Borst, P., Scheper, R. J., Mulder, H. S., DeVries, E. G., and Jansen, P. L. (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. U.S.A. 91, 13033-13037.
20. Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P. C., Deeley, R. G., and Keppler, D. (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269, 27807-27810.
21. Jedlitschky, G., Leier, I., Buchholz, U., Barnouin, K., Kurz, G., and Keppler, D. (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56, 988-994.
22. Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A., Zaman, G. J., Mayer, U., Beijnen, J. H., van der Valk, M., Krimpenfort, P., and Borst, P. (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3, 1275-1279.
23. Lorico, A., Rappa, G., Flavell, R. A., and Sartorelli, A. C. (1996) Double knockout of the MRP gene leads to increased drug sensitivity in vitro. Cancer Res. 56, 5351-5355.
24. Lorico, A., Rappa, G., Finch, R. A., Yang, D., Flavell, R. A., and Sartorelli, A. C. (1997) Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57, 5238-5242.
25. Ito, K., Suzuki, H., Hirohashi, T., Kume, K., Shimizu, T., and Sugiyama, Y. (1998) Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. J. Biol. Chem. 273, 1684-1688.
26. Taniguchi, K., Wada, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S.-I., and Kuwano, M. (1996) A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 56, 4124-4129.
27. Ishikawa, T., Bao, J. J., Yamane, Y., Akimaru, K., Frindrich, K., Wright, C. D., and Kuo, M. T. (1996). Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem. 271, 14981-14988.
28. Kala, S. V., Neely, M. W., Kala, G., Prater, C. I., Atwood, D. W., Rice, J. S., and Lieberman, M. W. (2000) The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275, 33404-33408.
29. Zelcer, N., Saeki, T., Reid, G., Beijnen, J. H., and Borst, P. (2001) Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J. Biol. Chem. 276, 46400-46407.
30. Kool, M., Linden, M. V., de Haas, M., Scheffer, G. L., De Vree, J. M., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N., Scheper, R. J., Elferink, R. P. J. O., Baas, F., and Borst, P. (1999) MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. U.S.A. 96, 6914-6919.
31. Ernest, S., Rajaraman, S., Megyesi, J., and Bello-Reuss, E. (1997) Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. Nephron 77, 284-289.
32. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 84, 7735-7738.
33. Gottesman, M., and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427.
34. Croop, J. M., Raymond, M., Harber, D., Devault, A., Arceci, R. J., Gros, P., and Houseman, D. E. (1989) The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell. Biol. 9, 1346-1350.
35. Schinkel, A. H., Smit, J. J. M., Van Tellingen, O., Beijinen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A., Van der Valk, M. A., Robanus-Maandag, E. C., te Riele H. P. T., Berns, A. J., and Borst, P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
36. Csanaky, I., Nemeti, B., and Gregus, Z. (2003) Dose-dependent biotransformation of arsenite in rats-not S-adenosylmethionine depletion impairs arsenic methylation at high dose. Toxicology 183, 77-91.
37. Zakharyan, R. A., Ayala-Fierro, F., Cullen, W. R., Carter, D. M., and Aposhian, H. V. (1999) Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Phamacol. 158, 9-15.
38. Styblo, M., Del Razo, M. L., LeCluyse, E. L., Hamilton, G. A., Wang, C., Cullen, W. R., and Thomas, D. J. (1999) Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem. Res. Toxicol. 12, 560-565.
39. Gregus, Z., Gyurasics, A., and Csanaky, I. (2000) Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56, 18-25.
40. Milstein, L. S., Essader, A., Pellizzari, E. D., Fernando, R. A., Raymer, J. H., Levine, K. E., and Akinbo, O. (2003) Development and application of a robust speciation method for determination of six arsenic compounds present in human urine. Environ. Health Perspect. 111, 293-296.
41. Suzuki, K. T., Tomita, T., Ogra, Y., and Ohmichi, M. (2001) Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats. Chem. Res. Toxicol. 14, 1604-1611.
42. Griffith, O. W., and Meister, A. (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254, 7558-7560.
43. Zakharayan, R., Wu, Y., Bogdan, G. M., and Aposhian, H. V. (1995) Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8, 1029-1038.
44. Styblo, M., Delnomdedieu, M., and Thomas, D. J. (1996) Mono-and dimethylation of arsenic in rat liver cytosol in vitro. Chem.-Biol. Interact. 99, 147-164.
45. Gekeler, V., Ise, W., Sanders, K. H., Ulrich, W. R., and Beck, J. (1995) The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208, 345-352.
46. Shen, H., Paul, S., Breuninger, L. M., Ciaccio, P. J., Liang, N. M., Helt, M., Tew, K. D., and Kruh, G. D. (1996) Cellular and in vitro transport of glutathione conjugates by MRP. Biochemistry 35, 5719-5725.
47. Leslie, E. M., Deeley, R. G., and Cole, S. P. (2001) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167, 3-23.
48. Liu, J., Chen, H., Miller, D. S., Saavedra, J. E., Keefer, L. K., Johnson, D. R., Klaassen, C. D., and Waalkes, M. P. (2001) Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol. Pharmacol. 60, 302-309.